Arkolith/Insider Trading/CADL/Form 4

Tak Paul Peter

Chief Executive Officer, DirectorCandel Therapeutics, Inc. (CADL) · full profile →Form 4 · filed Jan 10, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$174K
Net Open-Market Flow
-$174K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 8, 2025Sell(S)21K$8.22$174K274K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-004198) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML